Sagimet Biosciences Inc. Series A Common Stock (SGMT) — Net Asset Quality Index
Sagimet Biosciences Inc. Series A Common Stock (SGMT) has a Net Asset Quality Index of 97.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $263.43 Million minus total liabilities of $7.28 Million yields net assets of $256.15 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does Sagimet Biosciences Inc. Series A Common carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Sagimet Biosciences Inc. Series A Common Stock Net Asset Quality Index Over Time (2019–2025)
This chart shows how Sagimet Biosciences Inc. Series A Common Stock's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the index stands at 97.2%, representing net assets of $256.15 Million against total assets of $263.43 Million USD. For live market cap and overall valuation, see SGMT stock market capitalisation.
Annual Net Asset Quality Index for Sagimet Biosciences Inc. Series A Common Stock (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Sagimet Biosciences Inc. Series A Common Stock from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check how strategically is Sagimet Biosciences Inc. Series A Common's equity deployed to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 95.6% | $111.38 Million | $116.48 Million | $5.10 Million | ▼ -1.6 pp |
| 2024 | 97.2% | $155.81 Million | $160.26 Million | $4.45 Million | ▲ +3.1 pp |
| 2023 | 94.2% | $91.06 Million | $96.72 Million | $5.65 Million | ▲ +660.1 pp |
| 2022 | -566.0% | $-186.95 Million | $33.03 Million | $219.98 Million | ▼ -297.9 pp |
| 2021 | -268.1% | $-158.26 Million | $59.03 Million | $217.29 Million | ▼ -71.0 pp |
| 2020 | -197.1% | $-135.91 Million | $68.96 Million | $204.87 Million | ▲ +925.8 pp |
| 2019 | -1122.9% | $-125.31 Million | $11.16 Million | $136.47 Million | — |